Developed with ingredients listed by the U.S. Food and Drug Administration (FDA) in Title 21 of the Code of Federal Regulations (21 CFR) as direct or indirect food additives, these No-Tox® inks are typically used to print:
- disposable medical devices by offset gravure, pad print or silk screen printing,
- transdermal patches by flexography or gravure printing,
- package inserts by offset lithography, letterpress, or flexography, and
- medical packaging by form-fill-seal, flexography or gravure printing.
We maintain a drug master file at the FDA which can hold any formula we create. A drug master file (DMF) is a file that provides a full set of data on an active pharmaceutical ingredient (API). In some countries, the term may also comprise data on an excipient or a component of a product such as a printing ink or package. Upon your request and our authorization, the FDA can review any Colorcon formulation to ascertain its acceptability for any given application.
Flexographic/Gravure Pad Print/Screen Print Offset Gravure